Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3682423017 | Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3682425012 | Bendroflumethiazide 2.5 mg and propranolol hydrochloride 80 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Bendroflumethiazide and propranolol only product in oral dose form | true | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Propranolol hydrochloride | true | Inferred relationship | Some | 2 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Bendroflumethiazide (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Propranolol+diuretic (product) | false | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Diuretic (substance) | false | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Propranolol (substance) | false | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Propranolol hydrochloride + bendrofluazide (product) | false | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Bendroflumethiazide (substance) | false | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Bendrofluazide - chemical (substance) | false | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Propranolol hydrochloride | false | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | Capsule | false | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Product containing bendroflumethiazide and propranolol (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | a une forme pharmaceutique (attribut) | Oral capsule | true | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Propranolol-containing product in oral dose form | false | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Bendroflumethiazide (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Bendroflumethiazide (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 2.5 (qualifier value) | false | Inferred relationship | Some | 1 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | a pour principe actif (attribut) | Propranolol hydrochloride | false | Inferred relationship | Some | 2 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Propranolol hydrochloride | true | Inferred relationship | Some | 2 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 80 (qualifier value) | false | Inferred relationship | Some | 2 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 2 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Propranolol hydrochloride | false | Inferred relationship | Some | 1 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 80 (qualifier value) | false | Inferred relationship | Some | 1 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Bendroflumethiazide (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value (attribute) | 2.5 (qualifier value) | false | Inferred relationship | Some | 2 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | Bendroflumethiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Bendroflumethiazide (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Propranolol hydrochloride | false | Inferred relationship | Some | 1 | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets